Satyam (NYSE: SAY), a leading global business and information technology services company, today announced setting up of the Life Sciences Center of Excellence (CoE). The facility was inaugurated by Satyam’s founder and chairman, B Ramalinga Raju on the sidelines of RxCellence, the Life Science’s conclave which Satyam hosted at its state-of-art Satyam School of Leadership in Hyderabad. The theme for the conference was Faster, Safer and Smarter Strategies for Life Sciences Industry. The day was filled with compelling, insightful and thought-provoking speaker sessions and panel discussions on the progressive accomplishments in the pharmaceutical, biomedical and generics industry. Thought Leaders, CXOs, Business Leaders, Consultants, Analysts, Scientists and senior Executives from different parts of the world attended the event. Some of the eminent dignitaries were from the Life Sciences Advisory board members comprising ex-senior executives / ex-CXOs of leading Life S companies.
"Customers have moved on and ahead from the traditional services model. They are now looking at us, the service providers, to help identify tomorrow’s business challenges and collaborate proactively in building solutions and frameworks which deliver faster and better Return on Investments. We are setting up a number of CoEs for the industries we service.” said Ram Mynampati, President, Commercial and Healthcare Business, Satyam Computer Services Ltd.
The Life Sciences CoE will showcase Satyam’s domain expertise and thought leadership in the industry. The CoE will house solutions cutting across the value chain, addressing a number of industry pain points. While there are quite a few discrete point solutions attempting to address various industry pain points, they are often incomplete requiring huge amount of customization and complex integration. The CoE solutions will provide the necessary frameworks with flexibility and ease of customization enabling faster implementations and therefore a better RoI. These solutions leverage extensive domain experience that Satyam has built over the years in the industry. The CoE addresses industry needs in the areas of clinical drug accountability, drug counterfeiting, cell line management systems, high throughput analytics, clinical development, bioinformatics, Supply Chain, CRM, Key Opinion Leader portals etc.
“This is a significant step forward for us. We have been servicing customers in the Life Sciences industry for a number of years. We are now in a position to significantly contribute and help our customers in their efforts towards safer drugs to the market quickly in a cost effective manner by leveraging these innovative frameworks and solutions. This we believe will contribute towards greater access and affordability of healthcare globally” said Kishore Rachapudi, Global Head, Life Sciences, Satyam Computer Services Ltd.
The Satyam CoE solutions are being reviewed and validated regularly by their customers and the life sciences advisory board comprising eminent personalities with decades of experience in the industry. With all the inputs being received and the consequent refinements and enhancements being made, Satyam is confident that the organization will be able to make a step change in the quality and delivered value of services to customers.
Satyam (NYSE: SAY), a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and 61* countries.
Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company’s 49,199* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities.
Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 630* clients, including more than one third of the Fortune 500.
*As of Dec. 31, 2007